COVID-19 effect on clinical research: Single-site risk management experience
Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic is extensively impacting new and ongoing clinical trials of various medical products irrespective of indication. It has the potential to adverse effect not only in terms of recruitment and immediate patient care but is also likely...
Main Author: | Fatma Soliman Elsayed Ebeid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2020;volume=11;issue=3;spage=106;epage=110;aulast=Ebeid |
Similar Items
-
Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak
by: Anamika Pandey, et al.
Published: (2020-10-01) -
Clinical trials for coronavirus disease 2019: What is being evaluated and what is not
by: Yaseen M Arabi, et al.
Published: (2020-01-01) -
Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms
by: Chao Cao, et al.
Published: (2020-06-01) -
Clinical characteristics of COVID-19 in a tertiary health facility in northeast Nigeria
by: Ballah Akawu Denue, et al.
Published: (2021-01-01) -
Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study
by: Almalki ZS, et al.
Published: (2020-10-01)